New York Times Shares Fall After Weinstein Threatens Lawsuit
(Bloomberg) -- New York Times Co. shares fell the most in almost two months after a movie mogul threatened to sue the publisher over its article detailing allegations of sexual harassment.
Times shares dipped as much as 2.5 percent to $19.50 Friday, the biggest intraday decline in two months. Harvey Weinstein, famous for releasing Oscar winners such as “The English Patient” and “Shakespeare in Love,” took a leave of absence from his production company following the New York Times article on Thursday.
Actress Ashley Judd was among the people in the article who say they were harassed by the producer, who has been a fixture in Hollywood power circles for almost four decades. Weinstein has reached at least eight settlements with women, the newspaper reported, citing unnamed officials at the Weinstein Co., the film and TV production company Harvey founded in 2005 with his brother Bob.
Charles Harder, an attorney working with Weinstein, said in a statement that the article was “saturated with false and defamatory statements” and that his client is preparing to sue the newspaper. Harder is best known for winning a $140 million invasion of privacy lawsuit on behalf of wrestler Hulk Hogan against the website Gawker.
The New York Times has said it's confident in the accuracy of its story.
To contact the reporter on this story: Gerry Smith in New York at gsmith233@bloomberg.net.
To contact the editors responsible for this story: Crayton Harrison at tharrison5@bloomberg.net, Rob Golum
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.